Monoclonal antibodies to phosphatidylinositol phosphate neutralize human immunodeficiency virus type 1: role of phosphate-binding subsites.
about
Autoreactivity and Exceptional CDR Plasticity (but Not Unusual Polyspecificity) Hinder Elicitation of the Anti-HIV Antibody 4E10New cholesterol-specific antibodies remodel HIV-1 target cells' surface and inhibit their in vitro virus production.Multi-Parameter Exploration of HIV-1 Virus-Like Particles as Neutralizing Antibody Immunogens in Guinea Pigs, Rabbits and MacaquesOptimization and validation of the TZM-bl assay for standardized assessments of neutralizing antibodies against HIV-1.In-solution virus capture assay helps deconstruct heterogeneous antibody recognition of human immunodeficiency virus type 1Anti-phospholipid human monoclonal antibodies inhibit CCR5-tropic HIV-1 and induce beta-chemokinesDifferential inhibition of human immunodeficiency virus type 1 in peripheral blood mononuclear cells and TZM-bl cells by endotoxin-mediated chemokine and gamma interferon production.Microarray analysis of HIV resistant female sex workers reveal a gene expression signature pattern reminiscent of a lowered immune activation state.Multivalent dendrimeric compounds containing carbohydrates expressed on immune cells inhibit infection by primary isolates of HIV-1.Replication competent molecular clones of HIV-1 expressing Renilla luciferase facilitate the analysis of antibody inhibition in PBMC.Back to the future: covalent epitope-based HIV vaccine development.Detection of HIV-1 neutralizing antibodies in a human CD4⁺/CXCR4⁺/CCR5⁺ T-lymphoblastoid cell assay system.Neutralizing and other antiviral antibodies in HIV-1 infection and vaccination.Binding of anti-membrane-proximal gp41 monoclonal antibodies to CD4-liganded and -unliganded human immunodeficiency virus type 1 and simian immunodeficiency virus virionsNeutralizing epitopes in the membrane-proximal external region of HIV-1 gp41 are influenced by the transmembrane domain and the plasma membrane.Deficient synthesis of class-switched, HIV-neutralizing antibodies to the CD4 binding site and correction by electrophilic gp120 immunogen.Human immunodeficiency virus type 1 gp41 antibodies that mask membrane proximal region epitopes: antibody binding kinetics, induction, and potential for regulation in acute infectionThe membrane-proximal external region of the human immunodeficiency virus type 1 envelope: dominant site of antibody neutralization and target for vaccine designRational design of membrane proximal external region lipopeptides containing chemical modifications for HIV-1 vaccination.Cross-reactive human immunodeficiency virus type 1-neutralizing human monoclonal antibody that recognizes a novel conformational epitope on gp41 and lacks reactivity against self-antigens.The broadly neutralizing anti-human immunodeficiency virus type 1 4E10 monoclonal antibody is better adapted to membrane-bound epitope recognition and blocking than 2F5.Role of lipid structure in the humoral immune response in mice to covalent lipid-peptides from the membrane proximal region of HIV-1 gp41.Role of HIV membrane in neutralization by two broadly neutralizing antibodies.Immunotherapeutic restoration in HIV-infected individuals.Polyreactive antibodies in adaptive immune responses to viruses.Nonneutralizing HIV-1 gp41 envelope cluster II human monoclonal antibodies show polyreactivity for binding to phospholipids and protein autoantigens.Antibody-based HIV-1 vaccines: recent developments and future directions.Membrane-specific antibodies induced by liposomes can simultaneously bind to HIV-1 protein, peptide, and membrane lipid epitopes.
P2860
Q27680125-DDD5EC02-5D25-4EFB-8E48-FB5EBFF67746Q33577826-0669CADF-800C-4CE6-8BD1-D1AC2BCAF1BFQ33683203-D936847F-054A-4CFE-9F80-238589EBBE07Q33693391-A1C598DF-FF2A-4E07-A423-FC2DEA42F379Q33725718-35518289-BAB0-4E30-A5C5-B358FB8F2379Q33794973-51D12CAB-5359-42C7-8330-F2F33C27508BQ33827798-C0316C91-2D17-4D67-AF93-0C102E061A79Q34145864-890D97C6-E3B7-4289-A56E-10693B33B6CEQ34253227-94D40127-7EE2-45B8-AEFA-352275785675Q34357068-53B5D764-D949-4D91-A9D1-40E7CE6F54FAQ34597300-D955BE03-4CA1-4E9F-A8D1-B4B6826987DDQ35060140-5A387782-1E77-4047-A53C-240F043F397AQ35208657-AC678314-3AE5-44DD-A909-89FD2A45B492Q35689608-CE882B23-6683-4D24-AEFA-E429F4886718Q35826306-1A5610DF-CF31-4B24-A84C-A6B8C1FCC524Q36069818-8ABB708C-3723-481E-A9CF-E3EB3374B8DFQ36423897-DFA3E5FC-5DAD-47ED-B6A6-C355C898FCF8Q36497712-CA9D3FA4-B26A-499D-9814-93CC9B378078Q36504833-8ED997C3-3025-46C7-9C9A-0EC6FD698108Q36747750-907D01B2-28B9-4D1D-B73E-1D45CB16EAEAQ36898696-055D4283-42D4-4B6C-B846-045589D25E11Q37316019-ECFB4124-8F0B-4205-AE20-EA058E42CA1AQ37453499-DF840FE9-BD83-45DF-941C-D48F98A7B86DQ37842335-AD329453-A6CD-4101-B672-38A274B26532Q37951868-22FCA5B0-4888-4ED0-8FB7-342B2C80941DQ42170072-F5830A70-F421-49EA-87E8-4C8987B0B603Q42738983-47E87792-0D39-4C1F-BE03-A34EA08B2D12Q46441250-C8CA76BB-4975-4233-B712-7F1EB84E672C
P2860
Monoclonal antibodies to phosphatidylinositol phosphate neutralize human immunodeficiency virus type 1: role of phosphate-binding subsites.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Monoclonal antibodies to phosp ...... of phosphate-binding subsites.
@ast
Monoclonal antibodies to phosp ...... of phosphate-binding subsites.
@en
type
label
Monoclonal antibodies to phosp ...... of phosphate-binding subsites.
@ast
Monoclonal antibodies to phosp ...... of phosphate-binding subsites.
@en
prefLabel
Monoclonal antibodies to phosp ...... of phosphate-binding subsites.
@ast
Monoclonal antibodies to phosp ...... of phosphate-binding subsites.
@en
P2093
P2860
P356
P1433
P1476
Monoclonal antibodies to phosp ...... of phosphate-binding subsites.
@en
P2093
Bruce K Brown
Carl R Alving
Gary R Matyas
Nicos Karasavvas
Zoltan Beck
P2860
P304
P356
10.1128/JVI.02011-06
P407
P577
2006-12-06T00:00:00Z